NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,799 | +2.3% | 6,664 | +1.3% | 0.05% | +6.4% |
| Q2 2023 | $663,689 | +11.7% | 6,577 | +1.9% | 0.05% | +11.9% |
| Q1 2023 | $593,956 | -3.1% | 6,456 | -4.5% | 0.04% | -10.6% |
| Q4 2022 | $613,178 | +25.9% | 6,759 | +5.5% | 0.05% | +14.6% |
| Q3 2022 | $487,000 | -4.1% | 6,404 | +6.5% | 0.04% | 0.0% |
| Q2 2022 | $508,000 | -4.7% | 6,013 | -1.0% | 0.04% | +13.9% |
| Q1 2022 | $533,000 | -0.4% | 6,075 | -0.7% | 0.04% | +2.9% |
| Q4 2021 | $535,000 | +7.4% | 6,118 | +0.4% | 0.04% | -2.8% |
| Q3 2021 | $498,000 | -2.7% | 6,091 | +8.5% | 0.04% | -10.0% |
| Q2 2021 | $512,000 | +71.2% | 5,612 | +60.4% | 0.04% | +37.9% |
| Q1 2021 | $299,000 | -12.3% | 3,498 | -3.0% | 0.03% | -17.1% |
| Q4 2020 | $341,000 | -45.9% | 3,607 | -50.2% | 0.04% | -27.1% |
| Q3 2020 | $630,000 | +76.5% | 7,242 | +92.4% | 0.05% | +6.7% |
| Q4 2019 | $357,000 | – | 3,765 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |